NZ254207A - Tetracyclic derivatives antitumour medicaments and intermediate compounds (x and y are each s, c, o or n) - Google Patents
Tetracyclic derivatives antitumour medicaments and intermediate compounds (x and y are each s, c, o or n)Info
- Publication number
- NZ254207A NZ254207A NZ254207A NZ25420793A NZ254207A NZ 254207 A NZ254207 A NZ 254207A NZ 254207 A NZ254207 A NZ 254207A NZ 25420793 A NZ25420793 A NZ 25420793A NZ 254207 A NZ254207 A NZ 254207A
- Authority
- NZ
- New Zealand
- Prior art keywords
- alkyl
- tha
- carbon atoms
- carbazole
- optionally substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/333—Radicals substituted by oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929215361A GB9215361D0 (en) | 1992-07-20 | 1992-07-20 | Heterocyclic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ254207A true NZ254207A (en) | 1997-03-24 |
Family
ID=10718981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ254207A NZ254207A (en) | 1992-07-20 | 1993-07-19 | Tetracyclic derivatives antitumour medicaments and intermediate compounds (x and y are each s, c, o or n) |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0651750A1 (sh) |
| JP (1) | JPH08502037A (sh) |
| KR (1) | KR950702563A (sh) |
| CN (1) | CN1088209A (sh) |
| AU (1) | AU4579593A (sh) |
| BG (1) | BG99359A (sh) |
| CA (1) | CA2140662A1 (sh) |
| CZ (1) | CZ14995A3 (sh) |
| FI (1) | FI950229A (sh) |
| GB (1) | GB9215361D0 (sh) |
| HR (1) | HRP931066A2 (sh) |
| HU (1) | HUT76787A (sh) |
| IL (1) | IL106385A0 (sh) |
| MX (1) | MX9304355A (sh) |
| NO (1) | NO950202L (sh) |
| NZ (1) | NZ254207A (sh) |
| PL (1) | PL307169A1 (sh) |
| RU (1) | RU95104939A (sh) |
| SI (1) | SI9300390A (sh) |
| SK (1) | SK7595A3 (sh) |
| WO (1) | WO1994002483A1 (sh) |
| YU (1) | YU50293A (sh) |
| ZA (1) | ZA935213B (sh) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9401921D0 (en) * | 1994-02-01 | 1994-03-30 | Wellcome Found | Heterocyclic compounds |
| GB9413758D0 (en) * | 1994-07-07 | 1994-08-24 | Wellcome Found | Heterocyclic compounds |
| GB9804343D0 (en) * | 1998-02-27 | 1998-04-22 | Univ Cardiff | Chemical compounds |
| US7419992B2 (en) | 2001-02-14 | 2008-09-02 | Wisconsin Alumni Research Foundation | Use of aryl hydrocarbon receptor ligand as a therapeutic intervention in angiogenesis-implicated disorders |
| WO2002064138A1 (en) * | 2001-02-14 | 2002-08-22 | Wisconsin Alumni Research Foundation | Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| GB0302094D0 (en) | 2003-01-29 | 2003-02-26 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| GB0324269D0 (en) | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| WO2008051523A2 (en) * | 2006-10-23 | 2008-05-02 | Georgetown University | Carbazole derivatives useful as medicaments in cancer therapy |
| EP2484666A1 (en) | 2008-08-15 | 2012-08-08 | Georgetown University | Fluorescent regulators of RASSF1A expression and human cancer cell proliferation |
| JP2012051804A (ja) * | 2008-12-26 | 2012-03-15 | Kyoto Univ | Ｅｇ５阻害剤 |
| KR20160066490A (ko) | 2014-12-02 | 2016-06-10 | 주식회사 씨앤드씨신약연구소 | 헤테로사이클 유도체 및 그의 용도 |
| US11053255B2 (en) | 2015-06-22 | 2021-07-06 | Georgetown University | Synthesis of mahanine and related compounds |
| CN109776550B (zh) * | 2019-01-17 | 2021-08-10 | 广东轻工职业技术学院 | 一种海洋真菌来源的生物碱化合物及其在制备食品防腐剂中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0300688A1 (en) * | 1987-07-21 | 1989-01-25 | FISONS plc | Pyrrole derivatives, process for their preparation and pharmaceutical compositions containing them |
| US5166204A (en) * | 1989-11-01 | 1992-11-24 | Toyama Chemical Co., Ltd. | Isoindole derivatives and salts thereof and antitumor agent comprising the same |
| MC2251A1 (fr) * | 1990-03-20 | 1993-03-25 | Wellcome Found | Composes heterocycliques biocides,leur synthese et leurs internediaires,compositions les contenant et leur utilisation en medecine |
-
1992
- 1992-07-20 GB GB929215361A patent/GB9215361D0/en active Pending
-
1993
- 1993-07-19 CN CN93116598A patent/CN1088209A/zh active Pending
- 1993-07-19 JP JP6504272A patent/JPH08502037A/ja active Pending
- 1993-07-19 IL IL106385A patent/IL106385A0/xx unknown
- 1993-07-19 HR HR931066A patent/HRP931066A2/hr not_active Application Discontinuation
- 1993-07-19 WO PCT/GB1993/001512 patent/WO1994002483A1/en not_active Application Discontinuation
- 1993-07-19 RU RU95104939/04A patent/RU95104939A/ru unknown
- 1993-07-19 NZ NZ254207A patent/NZ254207A/en unknown
- 1993-07-19 MX MX9304355A patent/MX9304355A/es not_active IP Right Cessation
- 1993-07-19 AU AU45795/93A patent/AU4579593A/en not_active Abandoned
- 1993-07-19 CA CA002140662A patent/CA2140662A1/en not_active Abandoned
- 1993-07-19 CZ CZ95149A patent/CZ14995A3/cs unknown
- 1993-07-19 ZA ZA935213A patent/ZA935213B/xx unknown
- 1993-07-19 EP EP93916105A patent/EP0651750A1/en not_active Withdrawn
- 1993-07-19 HU HU9500171A patent/HUT76787A/hu unknown
- 1993-07-19 SI SI9300390A patent/SI9300390A/sl unknown
- 1993-07-19 PL PL93307169A patent/PL307169A1/xx unknown
- 1993-07-19 KR KR1019950700226A patent/KR950702563A/ko not_active Application Discontinuation
- 1993-07-19 SK SK75-95A patent/SK7595A3/sk unknown
- 1993-07-20 YU YU50293A patent/YU50293A/sh unknown
-
1995
- 1995-01-18 BG BG99359A patent/BG99359A/bg unknown
- 1995-01-19 FI FI950229A patent/FI950229A/fi unknown
- 1995-01-19 NO NO950202A patent/NO950202L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB9215361D0 (en) | 1992-09-02 |
| HRP931066A2 (en) | 1995-12-31 |
| IL106385A0 (en) | 1993-11-15 |
| EP0651750A1 (en) | 1995-05-10 |
| JPH08502037A (ja) | 1996-03-05 |
| ZA935213B (en) | 1995-01-19 |
| MX9304355A (es) | 1994-04-29 |
| FI950229A (fi) | 1995-03-10 |
| RU95104939A (ru) | 1996-10-27 |
| KR950702563A (ko) | 1995-07-29 |
| FI950229A0 (fi) | 1995-01-19 |
| BG99359A (bg) | 1995-11-30 |
| PL307169A1 (en) | 1995-05-15 |
| AU4579593A (en) | 1994-02-14 |
| YU50293A (sh) | 1997-01-08 |
| WO1994002483A1 (en) | 1994-02-03 |
| NO950202D0 (no) | 1995-01-19 |
| HUT76787A (en) | 1997-11-28 |
| SI9300390A (en) | 1994-03-31 |
| CA2140662A1 (en) | 1994-02-03 |
| HU9500171D0 (en) | 1995-03-28 |
| SK7595A3 (en) | 1995-07-11 |
| CZ14995A3 (en) | 1995-10-18 |
| NO950202L (no) | 1995-01-19 |
| CN1088209A (zh) | 1994-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7030093B2 (ja) | オキサチアジン様化合物を作製する方法 | |
| NZ254207A (en) | Tetracyclic derivatives antitumour medicaments and intermediate compounds (x and y are each s, c, o or n) | |
| CN100506821C (zh) | 四氢吡啶醚化合物 | |
| EP2686320A1 (en) | Tricyclic gyrase inhibitors | |
| WO2010099740A1 (zh) | 13a-(S)去氧娃儿藤宁衍生物、其制法和药物组合物与用途 | |
| HU220066B (hu) | Imidazo[1,2-a]piridinek alkoxi-alkil-karbamátjai, alkalmazásuk, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| JP2002517397A (ja) | 細胞毒性抗腫瘍剤としてのナフト及びジヒドロベンゾチオフェン誘導体 | |
| CA2201097A1 (en) | Anti-tumor agents | |
| CA2189760A1 (en) | Pyrrolocarbazole derivatives | |
| CA2485201A1 (en) | Camptothecins with a modified lactone ring | |
| US5679694A (en) | Tetracyclic compounds, intermediates for their preparation and their use as antitumor agents | |
| US7067666B2 (en) | 7-substituted camptothecin and camptothecin analogs and methods for producing the same | |
| WO1994017075A1 (en) | Diazepin derivatives and antiviral compositions | |
| ES2282564T3 (es) | Analogicos de la captotecina opticamente puros. | |
| ES2209196T3 (es) | Analogos opticamente puros de la camptotecina, producto intermedio de sintesis opticamente puro y su procedimiento de preparacion. | |
| US6201129B1 (en) | Tricyclic derivatives and their use as anti-cancer agents | |
| AU752505B2 (en) | New 8H-thieno-(2,3-b)pyrrolizin-8-one compounds, a process for their preparation and pharmaceutical compositions containing them | |
| WO2023215133A1 (en) | Pikfyve kinase inhibitors | |
| FR2581996A1 (fr) | Nouveaux derives 6-substitues de 6h-dibenzo(b, d)thiopyranne utiles notamment immunomodulateurs et antiviraux et leur preparation | |
| WO1995021171A1 (en) | Tricyclic derivatives and their use as anti-cancer agents | |
| CN116265474A (zh) | 新型喜树碱类化合物及其药物组合物和用途 | |
| CN112724130A (zh) | 抗流感病毒化合物及其制备方法和应用 | |
| ES2372769A1 (es) | Fenil metil sulfonas con actividad antiiflamatoria y actividad antitumoral. | |
| JPH11255746A (ja) | アザアズレン誘導体 |